Retatrutides clinical data shows significant reductions in HbA1c (1.8%), triglycerides (28% reduction), and blood pressure (6.8 mmHg systolic reduction)
Yes switching between semaglutide and tirzepatide is a normal part of the process
Potential Benefits of Retatrutide Peptide Potential benefits of retatrutide peptide center on obesity, body weight, glycemic control, liver-fat reduction, and cardiometabolic risk markers, but each benefit should be read by evidence level [4], [5], [6], [7], [9]
The result of combining both is a larger, more sustained GH pulse that neither compound produces alone, without the cortisol elevation or appetite stimulation associated with older secretagogues like GHRP-2 or GHRP-6
CrossRef Metabolic DysfunctionAssociated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances Dalia M